In this case-control study, the expression of genes encodingvitamin D receptor (VDR) and CYP24A1 in relapsing-remitting MS (RR-MS) patientswas compared with normal individuals in the Iranian population. This evidence concerns the gene VDR and myeloid sarcoma.